Patents by Inventor Jill Carton

Jill Carton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medical device for administering anti-IL-23 antibodies
    Patent number: 11939375
    Abstract: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
    Type: Grant
    Filed: February 22, 2021
    Date of Patent: March 26, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Jacqueline Benson, Jill Carton, Mark Cunningham, Yevgeniya Orlovsky, Robert Rauchenberger, Raymond Sweet
  • Artificial Cell Death Polypeptide For Chimeric Antigen Receptor And Uses Thereof
    Publication number: 20230382999
    Abstract: Provided are polynucleotides encoding inactivated cell surface receptors. Also provided are genetically engineered induced pluripotent stem cells (iPSCs) and derivative cells thereof expressing a chimeric antigen receptor (CAR) and methods of using the same. Also provided are compositions, polypeptides, vectors, and methods of manufacturing.
    Type: Application
    Filed: March 30, 2023
    Publication date: November 30, 2023
    Inventors: Michael Naso, Jill Carton, John Wheeler, Luis Borges
  • Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
    Patent number: 11661459
    Abstract: Provided are polynucleotides encoding inactivated cell surface receptors. Also provided are genetically engineered induced pluripotent stem cells (iPSCs) and derivative cells thereof expressing a chimeric antigen receptor (CAR) and methods of using the same. Also provided are compositions, polypeptides, vectors, and methods of manufacturing.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: May 30, 2023
    Assignee: Century Therapeutics, Inc.
    Inventors: Michael Naso, Jill Carton, John Wheeler, Luis Borges
  • Genetically Engineered Cells and Uses Thereof
    Publication number: 20220195396
    Abstract: Provided are genetically engineered induced pluripotent stem cells (iPSCs) and derivative cells thereof expressing a chimeric antigen receptor (CAR) and methods of using the same. Also provided are compositions, polypeptides, vectors, and methods of manufacturing.
    Type: Application
    Filed: December 1, 2021
    Publication date: June 23, 2022
    Inventors: Michael Naso, Jill Carton, Mark Wallet, Barry Morse, Luis Borges, Buddha Gurung, Hillary Quinn, Liam Campion, Heidi Jessup, Kenneth Brasel, Lucas Thompson
  • Genetically Engineered Cells and Uses Thereof
    Publication number: 20220184123
    Abstract: Provided are genetically engineered induced pluripotent stem cells (iPSCs) and derivative cells thereof expressing a chimeric antigen receptor (CAR) and methods of using the same. Also provided are compositions, polypeptides, vectors, and methods of manufacturing.
    Type: Application
    Filed: December 1, 2021
    Publication date: June 16, 2022
    Inventors: Michael Naso, Jill Carton, Mark Wallet, Barry Morse, Luis Borges, Hillary Quinn, Liam Campion, Buddha Gurung, Heidi Jessup, Kenneth Brasel, Lucas Thompson
  • Artificial Cell Death Polypeptide For Chimeric Antigen Receptor And Uses Thereof
    Publication number: 20220177592
    Abstract: Provided are polynucleotides encoding inactivated cell surface receptors. Also provided are genetically engineered induced pluripotent stem cells (iPSCs) and derivative cells thereof expressing a chimeric antigen receptor (CAR) and methods of using the same. Also provided are compositions, polypeptides, vectors, and methods of manufacturing.
    Type: Application
    Filed: December 1, 2021
    Publication date: June 9, 2022
    Inventors: Michael Naso, Jill Carton, John Wheeler, Luis Borges
  • Medical Device for Administering Anti-IL-23 Antibodies
    Publication number: 20210188966
    Abstract: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
    Type: Application
    Filed: February 22, 2021
    Publication date: June 24, 2021
    Inventors: Jacqueline Benson, Jill Carton, Mark Cunningham, Yevgeniya Orlovsky, Robert Rauchenberger, Raymond Sweet
  • Methods of treatment using human anti-IL-23 antibodies
    Patent number: 10954297
    Abstract: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: March 23, 2021
    Assignee: Janssen Biotech, Inc.
    Inventors: Jacqueline Benson, Jill Carton, Mark Cunningham, Yevgeniya Orlovsky, Robert Rauchenberger, Raymond Sweet
  • Methods of Treatment Using Human Anti-IL-23 Antibodies
    Publication number: 20180291096
    Abstract: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
    Type: Application
    Filed: June 20, 2018
    Publication date: October 11, 2018
    Inventors: Jacqueline Benson, Jill Carton, Mark Cunningham, Yevgeniya Orlovsky, Robert Rauchenberger, Raymond Sweet
  • Human anti-IL-23 antibodies, compositions, methods and uses
    Patent number: 10030070
    Abstract: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: July 24, 2018
    Assignee: Janssen Biotech, Inc.
    Inventors: Jacqueline Benson, Jill Carton, Mark Cunningham, Yevgeniya I. Orlovsky, Robert Rauchenberger, Raymond Sweet
  • Human Anti-IL-23 Antibodies, Compositions, Methods and Uses
    Publication number: 20170362316
    Abstract: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
    Type: Application
    Filed: September 1, 2017
    Publication date: December 21, 2017
    Inventors: Jacqueline Benson, Jill Carton, Mark Cunningham, Yevgeniya I. Orlovsky, Robert Rauchenberger, Raymond Sweet
  • Human anti-IL-23 antibodies, compositions, methods and uses
    Patent number: 9783607
    Abstract: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: October 10, 2017
    Assignee: Janssen Biotech, Inc.
    Inventors: Jacqueline Benson, Jill Carton, Mark Cunningham, Yevgeniya I. Orlovsky, Robert Rauchenberger, Raymond Sweet
  • Human Anti-IL-23 Antibodies, Compositions, Methods and Uses
    Publication number: 20160237151
    Abstract: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
    Type: Application
    Filed: April 29, 2016
    Publication date: August 18, 2016
    Inventors: Jacqueline Benson, Jill Carton, Mark Cunningham, Yevgeniya I. Orlovsky, Robert Rauchenberger, Raymond Sweet
  • Human anti-IL-23 antibodies, compositions, methods and uses
    Patent number: 9353181
    Abstract: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: May 31, 2016
    Assignee: Janssen Biotech, Inc.
    Inventors: Jacqueline Benson, Jill Carton, Mark Cunningham, Yevgeniya I. Orlovsky, Robert Rauchenberger, Raymond Sweet
  • Vectors, host cells, and methods of production and uses
    Patent number: 9206248
    Abstract: Antibody expression vectors and plasmids can incorporate various antibody gene portions for transcription of the antibody DNA and expression of the antibody in an appropriate host cell. The expression vectors and plasmids have restriction enzyme sites that facilitate ligation of antibody-encoding DNA into the vectors. The vectors incorporate enhancer and promoter sequences that can be varied to interact with transcription factors in the host cell and thereby control transcription of the antibody-encoding DNA. A kit can incorporate these vectors and plasmids.
    Type: Grant
    Filed: February 9, 2015
    Date of Patent: December 8, 2015
    Assignee: Janssen Biotech, Inc.
    Inventors: Jill Carton, Jin Lu, Bernard Scallon, Linda Snyder
  • Vectors, Host Cells, and Methods of Production and Uses
    Publication number: 20150147805
    Abstract: Antibody expression vectors and plasmids can incorporate various antibody gene portions for transcription of the antibody DNA and expression of the antibody in an appropriate host cell. The expression vectors and plasmids have restriction enzyme sites that facilitate ligation of antibody-encoding DNA into the vectors. The vectors incorporate enhancer and promoter sequences that can be varied to interact with transcription factors in the host cell and thereby control transcription of the antibody-encoding DNA. A kit can incorporate these vectors and plasmids.
    Type: Application
    Filed: February 9, 2015
    Publication date: May 28, 2015
    Inventors: Jill Carton, Jin Lu, Bernard Scallon, Linda Snyder
  • Vectors, host cells, and methods of production and uses
    Patent number: 8980626
    Abstract: Antibody expression vectors and plasmids can incorporate various antibody gene portions for transcription of the antibody DNA and expression of the antibody in an appropriate host cell. The expression vectors and plasmids have restriction enzyme sites that facilitate ligation of antibody-encoding DNA into the vectors. The vectors incorporate enhancer and promoter sequences that can be varied to interact with transcription factors in the host cell and thereby control transcription of the antibody-encoding DNA. A kit can incorporate these vectors and plasmids.
    Type: Grant
    Filed: January 24, 2014
    Date of Patent: March 17, 2015
    Assignee: Janssen Biotech, Inc.
    Inventors: Jill Carton, Jin Lu, Bernard Scallon, Linda Snyder
  • Vectors, Host Cells, and Methods of Production and Uses
    Publication number: 20140141506
    Abstract: Antibody expression vectors and plasmids can incorporate various antibody gene portions for transcription of the antibody DNA and expression of the antibody in an appropriate host cell. The expression vectors and plasmids have restriction enzyme sites that facilitate ligation of antibody-encoding DNA into the vectors. The vectors incorporate enhancer and promoter sequences that can be varied to interact with transcription factors in the host cell and thereby control transcription of the antibody-encoding DNA. A kit can incorporate these vectors and plasmids.
    Type: Application
    Filed: January 24, 2014
    Publication date: May 22, 2014
    Applicant: Janssen Biotech, Inc.
    Inventors: Jill Carton, Jin Lu, Bernard Scallon, Linda Snyder
  • Vectors, host cells, and methods of production and uses
    Patent number: 8663980
    Abstract: Antibody expression vectors and plasmids can incorporate various antibody gene portions for transcription of the antibody DNA and expression of the antibody in an appropriate host cell. The expression vectors and plasmids have restriction enzyme sites that facilitate ligation of antibody-encoding DNA into the vectors. The vectors incorporate enhancer and promoter sequences that can be varied to interact with transcription factors in the host cell and thereby control transcription of the antibody-encoding DNA. A kit can incorporate these vectors and plasmids.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: March 4, 2014
    Assignee: Janssen Biotech, Inc.
    Inventors: Jill Carton, Jin Lu, Bernard J. Scallon, Linda Snyder
  • Human Anti-IL-23 Antibodies, Compositions, Methods and Uses
    Publication number: 20120251454
    Abstract: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
    Type: Application
    Filed: June 15, 2012
    Publication date: October 4, 2012
    Inventors: Jacqueline Benson, Jill Carton, Mark Cunningham, Yevgeniya I. Orlovsky, Robert Rauchenberger, Raymond Sweet